Schedule 13G ownership disclosure

Capricor Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 14070B309

Event date: 2026-02-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 3,417,891.00 · Class: 6.6%

  • Averill Master Fund, Ltd.

    Shares: 2,917,420.00 · Class: 5.6%

  • Aaron Cowen

    Shares: 3,417,891.00 · Class: 6.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-001397
Form type
SCHEDULE 13G
Filer
CAPRICOR THERAPEUTICS, INC.
CIK
CIK 1133869
Filed
Feb 26, 2026
Reporting period
Feb 19, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub